Mylan Laboratories Limited Telmisartan Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Telmisartan Export Records India — #2 Exporter, 240 Shipments, $12.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Telmisartan

India Pharmaceutical Trade Intelligence

$11.0B413 Suppliers132 CountriesHS 30049079

ExportsIndia → GERMANY98.4%India → HUNGARY0.5%

ImportsGERMANY → India$1.9B MALTA → India$18.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: B LOGISTIK

Mylan Laboratories Limited — Telmisartan Exporter #2 | $12.0M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Telmisartan Exporter Profile

Indian Pharmaceutical Exporter · #2 for Telmisartan · $12.0M export value · DGFT Verified

Mylan Laboratories Limited is the #2 Indian exporter of Telmisartan with $12.0M in export value and 240 verified shipments. Mylan Laboratories Limited holds a 0.1% market share in Telmisartan exports across 4 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Telmisartan Export Profile: Buyers & Destinations

Mylan Laboratories Limited Telmisartan export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Telmisartan?

Country	Value	Shipments	Share
UNITED STATES	$3.7M	169	65.1%
HUNGARY	$1.8M	54	31.0%
NETHERLANDS	$172.2K	16	3.0%
SOUTH AFRICA	$50.0K	1	0.9%

Who Are the Top Buyers of Telmisartan from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.8M	77
MYLAN PHARMACEUTICALS INC	UNITED STATES	$1.3M	67
MYLAN HUNGARY KFT,	HUNGARY	$1.2M	37
MYLAN HUNGARY KFT	HUNGARY	$467.1K	10
M/S. MYLAN PHARMACEUTICALS INC,	UNITED STATES	$327.7K	13
MYLANPHARMACEUTICALS INC	UNITED STATES	$123.3K	4
MYLAN PHARMACEUTICALS INC.,	UNITED STATES	$118.8K	6
MYLAN B V	NETHERLANDS	$78.8K	6
M/S. MYLAN HUNGARY KFT,	HUNGARY	$68.1K	2
MYLAN B.V.,	NETHERLANDS	$51.9K	7

Mylan Laboratories Limited supplies Telmisartan to 17 buyers globally. The largest buyer is MYLAN PHARMACEUTICALS INC, (UNITED STATES), followed by MYLAN PHARMACEUTICALS INC (UNITED STATES) and MYLAN HUNGARY KFT, (HUNGARY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Telmisartan Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
HARMLESS MEDICINES, TELMISARTAN TABLETS	$390.7K	9
TELMISARTAN AND AMLODIPINE TABLETS USP 8	$343.8K	17
TELMISARTAN TABLETS USP 80 MG 30 BT TAB	$268.6K	6
TELMISARTAN TABLETS USP 80 MG 90 BT TAB	$242.4K	7
TELMISARTAN AND AMLODIPINE TABLETS USP 4	$184.5K	12
TELMISARTAN TABLETS USP 40 MG 90 BT PACK	$175.7K	8
HARMLESS MEDICINES,TELMISARTAN TAB 40MGAU/EU	$124.2K	3
TELMISARTAN TABLETS 40 MG	$100.0K	2
TELMISARTAN TABLETS 40MG	$100.0K	2
TELMISARTAN TABLETS 80MG PACKS 8000S	$100.0K	2

Mylan Laboratories Limited exports 126 distinct Telmisartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINES, TELMISARTAN TABLETS with 9 shipments worth $390.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Mylan Laboratories Limited Compare to Nearest Telmisartan Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED	$81.0M	1,619	5	$50.0K
3	INTAS PHARMACEUTICALS LIMITED	$15.5M	461	19	$33.7K
2	MYLAN LABORATORIES LIMITED ★	$12.0M	240	4	$50.0K
4	ARISTO PHARMACEUTICALS PRIVATE LIMITED	$11.6M	334	10	$34.8K
5	ALEMBIC PHARMACEUTICALS LIMITED	$11.0M	251	12	$43.7K

Mylan Laboratories Limited ranks #2 among 413 Indian Telmisartan exporters. Average shipment value of $50.0K compared to the market average of $416.8K. The closest competitors by value are CIPLA LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Telmisartan Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,766	15.9%
SAHAR AIR	1,729	15.6%
DELHI AIR CARGO ACC (INDEL4)	1,003	9.0%
NHAVA SHEVA SEA (INNSA1)	755	6.8%
DELHI AIR	623	5.6%
AHEMDABAD AIR	402	3.6%
Bombay Air	396	3.6%
JNPT	377	3.4%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Telmisartan Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Telmisartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 240 individual customs records matching Mylan Laboratories Limited exporting Telmisartan, covering 126 formulations to 4 countries via 17 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 132+ countries, 1,116+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Telmisartan

Telmisartan

Mylan Laboratories Limited — Telmisartan Exporter Profile

Mylan Laboratories Limited — Telmisartan Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Telmisartan?

Who Are the Top Buyers of Telmisartan from Mylan Laboratories Limited?

What Is India's Total Telmisartan Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Telmisartan Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Telmisartan Exporters?

What Telmisartan Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Telmisartan to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Telmisartan Exporters?

Which Indian Ports Ship Telmisartan Exports?

What Other Cardiovascular Products Does Mylan Laboratories Limited Export?

Telmisartan — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Telmisartan Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Telmisartan Export Data from Mylan Laboratories Limited

Telmisartan Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source